Wednesday December 19, 2018

Alcohol can be linked with seven types of Cancer: Research

While there has been evidence of an association between alcohol and cancer, the study claims it is causal, meaning it “directly causes cancer.”

1
//
Alcohol is linked with 7 cancers. Image Source: www.ndtv.com
Republish
Reprint
  • Researchers at the University of Otago in New Zealand said alcohol has a causal association with cancer of the oropharynx, larynx, esophagus, liver, colon, rectum and female breast
  • The risk of cancer from alcohol is largest among heavy drinkers but affects both light and moderate drinkers as well
  • 10 years of global data by groups such as the World Cancer Research Fund and the American Institute for Cancer Research and the International Agency for Research on Cancer were taken into account

New research links alcohol with seven types of cancer. Writing in the journal Addiction, researchers at the University of Otago in New Zealand say alcohol has a causal association with cancer of the oropharynx, larynx, esophagus, liver, colon, rectum and female breast.

Connection between Alcohol and Cancer. Image Source: www.cancernetwork.com
Connection between Alcohol and Cancer. Image Source: www.cancernetwork.com

While there has been evidence of an association between alcohol and cancer, the study claims it is causal, meaning it “directly causes cancer.”

The study was large, taking into account 10 years of global data collected by groups such as the World Cancer Research Fund and the American Institute for Cancer Research and the International Agency for Research on Cancer.

Follow NewsGram on Twitter

The risk of cancer from alcohol is largest among heavy drinkers, but affects both light and moderate drinkers as well.

According to the study, alcohol was responsible for 5.8 percent of all cancer deaths in 2012.

Jana Witt (Cancer Research UK). Image Source: www.researchgate.net
Jana Witt (Cancer Research UK). Image Source: www.researchgate.net

“We know that nine in 10 people aren’t aware of the link between alcohol and cancer,” Jana Witt of Cancer Research UK, who did not contribute to the study, told The Guardian newspaper. “And this review is a stark reminder that there’s strong evidence linking the two.”

Follow NewsGram on Facebook

And if you’re thinking that a little wine may help fight cardiovascular disease, this new study finds that the “evidence that moderate drinking provides protection against cardiovascular disease is not strong.” (VOA)

 ALSO READ:
Click here for reuse options!
Copyright 2016 NewsGram

  • Antara

    Such researches can help a great deal in keeping consumption in check!

Next Story

New Drug to Give Hopes to Bone Marrow Cancer Patients

It reduced the risk of progression or death by more than 50 per cent in both groups

0
Cancer
Cancer Ribbon. Pixabay

A therapeutic drug has been found to improve outcomes and survival rates for patients with a serious type of bone marrow cancer.

In a clinical trial by researchers at Newcastle University in Britain, patients with newly diagnosed myeloma were treated with a drug called lenalidomide.

The results, published in the journal The Lancet Oncology, showed an improvement for those who received lenalidomide drug, compared to those not receiving it.

“This is a major breakthrough as it shows that the long-term use of lenalidomide significantly improves the time myeloma patients stay in remission after initial therapy,” said Professor Graham Jackson from the Northern Institute for Cancer Research at Newcastle.

Myeloma is a cancer of the plasma cells and it can affect several areas of the body, such as the spine, skull, pelvis and ribs. Current treatment usually involves chemotherapy and a stem-cell transplant.

cancer
New drug offers hope for bone marrow cancer patients. Pixabay

“It is a huge step and, importantly, identifies that for younger patients lenalidomide improves their overall survival for this difficult-to-treat bone marrow cancer,” Jackson said.

“Our research highlights that lenalidomide should be considered for newly diagnosed patients following stem-cell transplantation,” he added.

As part of the study, a total of 1,137 newly diagnosed patients were randomly assigned to lenalidomide maintenance therapy and 834 patients to observation – this was after they completed their initial treatment.

Also Read- Narendra Modi Accuses Congress of Aiding Those Who Want to Weaken Army

The results show that lenalidomide can prolong the average remission time by more than two years in younger patients and by well over a year in older, less fit patients.

It reduced the risk of progression or death by more than 50 per cent in both groups. (IANS)